Key result
Optimal treatment for secondary mitral regurgitation remains debated without definitive consensus.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No standardized approach supported for secondary MR; leaves open the need for definitive trials to resolve ongoing debate.
International audience
No takes yet. Share an insight, caveat, or question.
Petrus et al. (2019) studied this question. Optimal treatment strategies for secondary mitral regurgitation remain a subject of ongoing clinical debate without a definitive consensus.
Synapse has enriched 10 related papers. Consider them for comparative context: